HiberGene Diagnostics
Sandyford
About HiberGene Diagnostics
Hibergene Diagnostics is a Dublin-based, private Irish company, that develops, manufactures and markets molecular diagnostic tests for human infectious diseases, using the LAMP (Loop Mediated Isothermal Amplification) technology. The company has a growing portfolio of tests, with tests for Meningococcus and Group B Streptococcus already available. In addition, Hibergene has an active research pipeline from which the company expects to release a number of tests on a yearly basis. The tests meet a significant unmet clinical need allowing clinicians to rapidly, accurately and easily detect human infectious diseases in a near patient setting. The company CEO is Brendan Farrell, an industry veteran, who was a founder of Trinity Biotech. The company is headquartered in Ireland and its investors include a number of institutions and private investors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $10.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2017)
- Website: hibergene.com
- Phone: +35319053160
Industries & Categories
Biotechnology, Health Diagnostics, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/hibergene-diagnostics-191036 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.